Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is a medical technology company with a positive outlook due to its strong financials, innovative R&D, and numerous market-expanding catalysts. With above-average revenue growth, attractive gross margin, and a disruptive breast implant technology, the company has potential to capture share from entrenched players in newer markets. Risks include economic recession, competition, unexpected complications, and unsuccessful product launches. The company is valued at $84 based on an EV/sales multiple of 10.0x its 2026E revenue estimate, higher than its peers due to its faster revenue growth.

Bears say

Establishment Labs Hldgs is a medical technology company with a negative outlook due to the delayed timeline for FDA approval for its Motiva label expansion for primary and revision breast reconstruction, which is not expected until 2025. It has potential for future growth with differentiated breast implant technologies and minimally invasive surgical techniques, but potential upside drivers include stronger US Motiva sales and better margins and international growth are unclear due to uncertainties in the FDA review process.

ESTA has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 7 analysts, ESTA has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.